The STEP trial program demonstrated that semaglutide produces average weight loss of 15% to 17% of total body weight, outcomes that were previously achievable only through bariatric surgery
Both she and the company declined to comment
[Abstract]2021 Jun 18;4(8):e202000906
Emanuela Arvat, Lidia Di Vito, Barbara Maccagno, Fabio Broglio, Muni F Boghen, Romano Deghenghi, Franco Camanni, Ezio Ghigo, Effects of GHRP-2 and Hexarelin, Two Synthetic GH-Releasing Peptides, on GH, Prolactin, ACTH and Cortisol Levels in Man
Muskiet MHA, Tonneijck L, Huang Y, et al
Does my insurance cover FDA-approved weight loss medications